Page 110 - Mployee Wellness Programs News Today

For breast cancer, 20.5% of patients received a screening in the year prior to being on Medicare, compared to 30.4% in the first year of being on Medicare, according to an Epic Research report. For colorectal cancer, screening rates jumped from 6% in the year before being on Medicare to 11% in the first year of being on Medicare.

Executives from Geisinger and UNC Health discussed the most impactful ways they have deployed predictive AI across their health systems during a recent virtual panel. At Geisinger, these predictive algorithms are reducing avoidable emergency department admissions, and at UNC, they are helping to identify sepsis before it becomes severe.

The food as medicine movement is gaining momentum, but there are several challenges, according to a PitchBook report. These challenges include resistance to diet restrictions and difficulty in tracking compliance.

Spring Health's Family Care solution now serves kids of all ages and their parents. It connects each family with a care navigator and offers a dashboard that allows parents and caregivers to track their child's care.

UnitedHealthcare awarded grants to 66 nonprofits across 12 states. The grants will support those struggling with social isolation, behavioral health, food insecurity and other social determinants of health.

Rich multimedia content, chatbots and human interaction all play important roles in helping new health technologies become part of a patient’s lifestyle.

While Octapharma drug Balfaxar met the goal of its pivotal clinical trial, more deaths and blood clot problems were reported in the study drug arm versus the comparator group. The FDA is requiring a post-marketing study to further assess the drug’s risks.

Biohaven’s bid to bring to market the first drug for rare neuromuscular disorder spinocerebellar ataxia has hit a setback. The FDA is refusing to review the drug’s application, a decision that could indicate the agency wants another clinical trial.

NorthShore University HealthSystem teamed up with Laguna Health in 2021 to study whether greater post-acute care support can improve patient recovery and reduce readmissions. The research partners recently released results of the study, which found that giving patients emotional and psychological support after their discharge hastens recovery, decreases costs and alleviates physician burnout.

Nexo Therapeutics is developing cancer drugs that expand the scope of amino acids addressable by covalent chemistry. Versant Ventures founded the startup and led its Series A financing.